Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Oct 21;2018:5264195. doi: 10.1155/2018/5264195

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2018 Luca Navarini et al.

This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

(a) Levels of resolvin D1 (RvD1) in plasma from SLE patients with low C4 levels (<0.1 g/l) (N = 10) and SLE patients with normal C4 levels (>0.1 g/l) (N = 20). (b) Levels of resolvin D1 (RvD1) in plasma from SLE patients with low C3 levels (<0.9 g/l) (N = 19) and SLE patients with normal C4 levels (>0.9 g/l) (N = 11). (c) Levels of resolvin D1 (RvD1) in plasma from anti-dsDNA antibody-positive SLE patients (N = 18) and anti-dsDNA antibody-negative SLE patients (N = 12). (d) Levels of resolvin D1 (RvD1) in plasma from SLE patients with SELENA-SLEDAI ≤ 3 (N = 10) and SLE patients with SELENA-SLEDAI > 3 (N = 20). (e) Levels of resolvin D1 (RvD1) in plasma from SLE patients with SDI = 0 (N = 15) and SLE patients with SDI ≥ 1 (N = 15). (f) Levels of resolvin D1 (RvD1) in plasma from SLE patients without antiphospholipid syndrome (APS) (N = 21) and SLE patients with APS (N = 9). Data are expressed as pg/ml, median (horizontal bar) with 25th and 75th percentile (boxes), and minimum and maximum (bars) (^∗∗p = 0.0087).